Skip to main content

Usana Health Sciences Inc

USNA
Exchange
NYSE
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0000896264

No open-market purchases or sales by Usana Health Sciences Inc insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $243.0M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Usana Health Sciences Inc changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of USNA: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders177169−8
Shares10.4M10.3M−174.2K (−1.7%)
Value$658.3M$646.8M−$11.5M (−1.7%)

New holders (14)

Institutions that held Usana Health Sciences Inc at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to USNA in Q2 2023
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP12,704$801.0K0.08%
Trexquant Investment LP7,135$449.8K0.01%
XTX Topco Ltd6,084$383.5K0.07%
Harbor Capital Advisors, Inc.4,865$306.7K0.06%
Qube Research & Technologies Ltd4,683$295.2K0.00%
Dark Forest Capital Management LP3,943$248.6K0.03%
Point72 Middle East FZE2,566$161.8K0.01%
Lazard Asset Management LLC753$47.0K0.00%
Altshuler Shaham Ltd434$27.4K0.00%
Simplex Trading, LLC102$6.00K0.00%
Avion Wealth26$1.00K0.00%
Point72 Asset Management, L.P.9$5670.00%
Abound Wealth Management6$3790.00%
SJS Investment Consulting Inc.1$640.00%

Sold out (22)

Institutions that held Usana Health Sciences Inc at the end of Q1 2023 and filed for Q2 2023 without it.